ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk Wins EU Label Update For Rybelsus To Include Heart Benefits
(RTTNews) - Novo Nordisk B A/S (NVO), Monday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has approved a label update for Rybelsus to include cardiovascular benefits demonstrated in the SOUL trial.
Announcement as on 15 September 2025

European shares rise as Inditex leads retailers, Novo Nordisk shines
European shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated sales. Novo Nordisk also saw gains following its restructuring announcement, including workforce reductions, aimed a
Announcement as on 10 September 2025

Novo Nordisk ties up with Apollo Clinics for obesity management initiative
Novo Nordisk partners with Apollo Clinics to tackle obesity in India. The collaboration introduces a comprehensive obesity management programme across Indian cities. This initiative aims to provide structured care through multiple levels. The partnership f
Announcement as on 01 September 2025

European stocks rise as Novo Nordisk lifts healthcare on Wegovy data
Shares of Novo Nordisk, the fourth-largest healthcare company on the STOXX index, climbed 3.1% after the company said Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly's rival medicines Mounjaro and Zepbound in a real-world compa
Announcement as on 01 September 2025

Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.72
  • 12Day Average: 38.35
  • 20Day Average: 38.67
  • 50Day Average: 48.55
  • 100Day Average: 48.98
  • 150Day Average: 51.37
  • 200Day Average: 55.17

NVO Indicators & signals

Indicator MACD (12,26,9)

38.44, 41.25, -3.17
Indicator MACD is in negative zone

Indicator ADX (14)

40.66, 16.36, 38.79
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Fri Mar 2026 36.54 35.86 to 37.33 -1.43% 1.42 times
19 Thu Mar 2026 37.07 36.17 to 37.47 -3.56% 1.13 times
17 Tue Mar 2026 38.44 38.30 to 39.27 -0.36% 0.65 times
16 Mon Mar 2026 38.58 37.79 to 38.59 1.63% 0.74 times
13 Fri Mar 2026 37.96 37.70 to 38.80 -0.16% 0.74 times
12 Thu Mar 2026 38.02 37.85 to 39.02 -2.14% 1.1 times
11 Wed Mar 2026 38.85 38.36 to 39.13 0.34% 0.66 times
10 Tue Mar 2026 38.72 38.18 to 39.22 -2.76% 1.34 times
09 Mon Mar 2026 39.82 37.68 to 39.88 3.21% 1.26 times
06 Fri Mar 2026 38.58 38.17 to 38.85 -1.25% 0.99 times
05 Thu Mar 2026 39.07 38.08 to 39.12 1.48% 1.39 times
04 Wed Mar 2026 38.50 37.29 to 38.60 5.02% 1.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top